ACADIA Pharmaceuticals Inc. (ACAD) Documents: SEC Filings, Investor Presentations & Press Releases

ACADIA Pharmaceuticals Inc. (ACAD) documents, SEC filings and the IR site together: 123 documents, newest first; latest 2026-08-12. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-12Press releaseAcadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-08-0510-QForm 10-Q for the quarter ended Jun 30
2026-08-04DeckEarnings presentation · Q2 2026 · Aug 2026
2026-08-04Press releaseAcadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on
2026-08-048-KForm 8-K, Item 2.02 results
2026-05-298-KForm 8-K, Item 5.02
2026-05-0710-QForm 10-Q for the quarter ended Mar 31
2026-05-06Press releaseAcadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
2026-05-06DeckPresentation of Q1 2026
2026-05-068-KForm 8-K, Item 2.02 results
2026-05-018-KForm 8-K, Item 5.02
2026-04-24ProxyDefinitive proxy statement
2026-03-058-KForm 8-K, Item 5.02
2026-03-01TranscriptQ4 FY25 earnings call transcript
2026-02-2610-KAnnual report on Form 10-K, FY25
2026-02-25DeckInvestor presentation · Q4 2025 · Feb 2026
2026-02-258-KForm 8-K, Item 2.02 results
2026-01-13Press releaseAcadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on
2026-01-13DeckInvestor presentation · Jan 2026
2026-01-138-KForm 8-K, Item 2.02 results
2025-11-0610-QForm 10-Q for the quarter ended Sep 30
2025-11-05Press releaseAcadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview
2025-11-05Press releaseAcadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview
2025-11-058-KForm 8-K, Item 2.02 results
2025-11-038-KForm 8-K, Item 5.02
2025-08-0710-QForm 10-Q for the quarter ended Jun 30
2025-08-06Press releaseAcadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview
2025-08-068-KForm 8-K, Item 2.02 results
2025-06-25DeckInvestor presentation · Jun 2025
2025-06-108-KForm 8-K, Item 8.01
2025-05-298-KForm 8-K, Item 5.07
2025-05-208-KForm 8-K, Item 1.01
2025-05-0810-QForm 10-Q for the quarter ended Mar 31
2025-05-078-KForm 8-K, Item 2.02 results
2025-04-25ProxyDefinitive proxy statement
2025-04-168-KForm 8-K, Item 5.03
2025-02-2710-KAnnual report on Form 10-K, FY24
2025-02-268-KForm 8-K, Item 2.02 results
2024-12-118-KForm 8-K, Item 2.01
2024-11-208-KForm 8-K, Item 5.02

ACAD overview · ACAD earnings · ACAD financials · ACAD KPIs · ACAD ownership · ACAD peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.